1. Home
  2. TLSA vs RPID Comparison

TLSA vs RPID Comparison

Compare TLSA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.37

Market Cap

192.1M

Sector

Health Care

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$3.87

Market Cap

204.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
RPID
Founded
2013
2006
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.1M
204.3M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
TLSA
RPID
Price
$1.37
$3.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
342.9K
357.0K
Earning Date
05-06-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,523,000.00
Revenue This Year
N/A
$19.91
Revenue Next Year
N/A
$21.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.63
52 Week Low
$0.63
$1.86
52 Week High
$2.60
$4.94

Technical Indicators

Market Signals
Indicator
TLSA
RPID
Relative Strength Index (RSI) 35.75 45.91
Support Level $1.25 $3.67
Resistance Level $1.77 $4.36
Average True Range (ATR) 0.11 0.40
MACD -0.03 -0.08
Stochastic Oscillator 5.77 2.36

Price Performance

Historical Comparison
TLSA
RPID

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: